Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | June 06, 2025 |
| Number of Shares Purchased | 827,966 |
| Highest Price Paid (p) | 406.10 |
| Lowest Price Paid (p) | 401.80 |
| Volume Weighted Average Price (p) | 404.24 |
| Registered Share Capital | 9,001,265,601 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 8,997,185,396 |
Material Changes
Following the settlement of the June 6 transaction, the Company's share capital structure was updated. The number of ordinary shares with voting rights is now 8,997,185,396. This figure is the relevant metric for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It is a statutory disclosure of a specific share transaction. The announcement explicitly states it does not constitute an offer or solicitation of an offer for securities.
Key Facts for Investor Verification
- Verify the total number of voting shares outstanding (8,997,185,396) for compliance with disclosure thresholds.
- Confirm the execution of the buyback programme initiated on March 28, 2025.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular pricing data.
- Note that this filing does not contain financial performance results for the period.